Open the mobile version, with barcode scanning
Class II Terminated

Adenosine Injection, USP, 60mg/20mL (3 mg/mL), 20 mL single-dose vial, Rx only, Manufactured by: Teva Pharmaceuticals USA Inc. Parsippany, NJ 07054, NDC 0703-8776-01

Why: Lack of Assurance of Sterility

Company
Teva Pharmaceuticals USA
Parsippany, NJ, United States
Reported
Aug 25, 2021
Recall started
Jul 29, 2021
Ended
Jun 4, 2024
Where sold
Product was distributed Nationwide, including Puerto Rico.
Amount
4,249 vials
Full product description
Adenosine Injection, USP, 60mg/20mL (3 mg/mL), 20 mL single-dose vial, Rx only, Manufactured by: Teva Pharmaceuticals USA Inc. Parsippany, NJ 07054, NDC 0703-8776-01
Lots / codes affected
Lot #: 100022400, exp. date 04/2023

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.